Oxidative stress and triglycerides as predictors of subclinical atherosclerosis in prediabetes

Redox Report

Volumn 19, Issue 2, 2014, Pages 87-91

  Al Aubaidy, Hayder A ^a   Jelinek, Herbert F ^a,b,c  

^a CHARLES STURT UNIVERSITY   (Australia)

^b MACQUARIE UNIVERSITY   (Australia)

^c KHALIFA UNIVERSITY   (United Arab Emirates)

Author keywords

8 OHdG; Atherosclerosis; Glutathione; Impaired fasting glucose; Triglycerides

Indexed keywords

8-OHDG; ATHEROSCLEROSIS; GLUTATHIONE; IMPAIRED FASTING GLUCOSE; TRIGLYCERIDES;

ATHEROSCLEROSIS; FASTING; GLUTATHIONE; HUMANS; OXIDATIVE STRESS; PREDIABETIC STATE; TRIGLYCERIDES;

EID: 84894360156     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/1351000213Y.0000000080     Document Type: Article

References (35)

1. Grundy S. Atherogenic dyslipidemia: lipoprotein abnormalities and implications for therapy. Am J Cardiol 1995;75:45B-52B.
2. Almeida EA, Morales RA, Ozaki MR. Endothelial dysfunction, lipid peroxidation and cholesterol level in rabbit arteries: relationship to progressive hypercholesterolemia. Clín Invest Arterioscler 2007;19(6):293-9.
3. Balagopal P, de Ferranti SD, Cook S, Daniels SR, Gidding SS, Hayman LL, McCrindle BW, Mietus-Snyder ML, Steinberger J. Nontraditional risk factors and biomarkers for cardiovascular disease: mechanistic, research, and clinical considerations for youth: a scientific statement from the American Heart Association. Circulation 2011;123(23):2749-69.
4. Al-Benna S, Hamilton CA, McClure JD, Rogers PN, Berg GA, Ford I, et al. Low-density lipoprotein cholesterol determines oxi-dative stress and endothelial dysfunction in saphenous veins from patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2006;26(1):218-23.
5. Mehta JL, Rasouli N, Sinha AK, Molavi B. Oxidative stress in diabetes: a mechanistic overview of its effects on atherogenesis and myocardial dysfunction. Int J Biochem Cell Biol Diab 2006;38(5-6):794-803.
6. Al-Aubaidy HA, Jelinek HF. Oxidative DNA damage: antioxi-dant response in postprandial hyperglycaemia in type 2 diabetes mellitus. Br J Diab Vasc Dis 2011;11(2):87-91.
7. Al-Aubaidy HA, Jelinek HF. Preclinical DNA damage assessed by 8-hydroxy-2-deoxy-guanosine in a rural diabetes screening clinic. Redox Rep 2010;15(3):1-7.
8. Madamanchi NR, Runge MS. Mitochondrial dysfunction in atherosclerosis. Circ Res 2007;100(4):460-73.
9. Blasiak J, Arabski M, Krupa R, Wozniak K, Zadrozny M, Kasznicki J, et al. DNA damage and repair in type 2 diabetes mellitus. Mutat Res 2004;554(1-2):279-304.
10. Rosello-Lleti E, de Burgos FG, Morillas P, Cortes R, Martinez-Dolz L, Almenar L, et al. Impact of cardiovascular risk factors and inflammatory status on urinary 8-OHdG in essential hypertension. Am J Hypertens 2012;25(2):236-42.
11. Botto N, Rizza A, Colombo M, Mazzone A, Manfredi S, Masetti S, et al. Evidence for DNA damage in patients with coronary artery disease. Mutat Res 2001;493:23-30.
12. Martinet W, Knaapen MW, De Meyer GR, Herman AG, Kockx MM. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 2002; 106(8):927-32.
13. Lonkar P, Dedon PC. Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates. Int J Cancer 2011;128(9):1999-2009.
14. Hochstein P, Atallah AS. The nature of oxidants and antioxidant systems in the inhibition of mutation and cancer. Mutat Res 1988;202:363-75.
15. Mehta J, Rasouli N, Sinha A, Molavi B. Oxidative stress in diabetes: a mechanistic overview of its effects on atherogenesis and myocardial dysfunction. Int J Biochem Cell Biol 2006;38: 794-803.
16. Nwose EU, Jelinek HF, Richards RS, Kerr PG. Changes in the erythrocyte glutathione concentration in the course of diabetes mellitus. Redox Rep 2006;11(3):99-104.
17. McLennan SV, Heffernan S, Wright L, Rae C, Fisher E, Yue DK, et al. Changes in hepatic glutathione metabolism in diabetes. Diabetes 1991;40(3):344-8.
18. Xiong Y, Uys JD, Tew KD, Townsend DM. S-glutathionylation: from molecular mechanisms to health outcomes. Antioxid Redox Signal 2011;15(1):233-70.
19. American Diabetes Association. Diagnosis & classification of diabetes mellitus. Diab Care 2004;27(1):S5-10.
20. Kanias T, Wong K, Acker JP. Determination of lipid peroxidation in desiccated red blood cells. Cell Preservation Technol 2007;5(3):165-74.
21. Friedewald W, Levy R, Frederickson D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugation. Clin Chem 1972;18:499-502.
22. Onat A, Can G, Kaya H, Hergenc G Atherogenic index of plasma' (log10 triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events. J Clin Lipidol 2010;4(2):89-98.
23. Dobiasova M, Frohlich J. The plasma parameter log (TG/ HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FERHDL). Clin Biochem 2001;34:583-8.
24. Noiri E, Nakao A, Uchida K, Tsukahara H, Ohno M, Fujita T, et al. Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal 2001;281(5):F948-57.
25. Lowry O, Passonneau J, Hasselberger F, Schulz D. Effects of ischemia on known substrates and cofactors of the glycolytic pathway in the brain. J Biol Chem 1964;239:18.
26. Pankow JS, Kwan DK, Duncan BB, Schmidt MI, Couper DJ, Golden S, et al. Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the Atherosclerosis Risk in Communities Study. Diab Care 2007;30(2):325-31.
27. Bertoni AG, Wong ND, Shea S, Ma S, Liu K, Preethi S, et al. Insulin resistance, metabolic syndrome, and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). Diab Care 2007;30(11):2951-56.
28. Chamnan P, Simmons RK, Khaw KT, Wareham NJ, Griffin SJ. Change in HbA1c over 3 years does not improve the prediction of cardiovascular disease over and above HbA1c measured at a single time point. Diabetologia 2013;56(5):1004-11.
29. Pradhan AD, Rifai N, Buring JE, Ridker PM. Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med 2007;120(8):720-7.
30. Criqui MH, Heiss G, Cohn R, Cowan LD, Suchindran CM, Bangdiwala S, et al. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med 1993;328(17): 1220-5.
31. Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2011;123(20):2292-333.
32. Al-Aubaidy HA, Jelinek HF. Oxidative DNA damage and obesity in type 2 diabetes mellitus. Eur J Endocrinol 2011; 164(6):899-904.
33. West KM, Ahuja MMS, Bennett PH, Czyzyk A, De Acosta OM, Fuller JH, et al. The role of circulating glucose and triglyceride concentrations and their interactions with other 'risk factors' as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diab Care 1983; 6(4):361-9.
34. Song F, Jia W, Yao Y, Hu Y, Lei L, Lin J, et al. Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed type 2 diabetes. Clin Sci 2007;112(12):599-606.
35. Zengi A, Ercan G, Caglayan O, Tamsel S, Karadeniz M, Simsir I, et al. Increased oxidative DNA damage in lean normoglycemic offspring of type 2 diabetic patients. Exp Clin Endocrinol Diab 2011;119(EFirst):467-71.